Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Golgin, RAB6-interacting (GORAB) is a member of the golgin family of coiled-coil proteins that localize to the Golgi apparatus and are crucial for proper Golgi structure and vesicle tethering[2][3]. GORAB interacts with the small GTPase RAB6, mediating its association with the trans-Golgi network, and also binds to Sas6 to facilitate proper centriole duplication, indicating dual roles in both Golgi and centriole function[2]. Mutations in GORAB are causative of gerodermia osteodysplastica, a genetic disorder characterized by connective tissue abnormalities[2][4]. Although GORAB participates in key structural and organizational aspects of intracellular trafficking and organelle architecture, it is not currently considered a druggable or therapeutic target such as a receptor or enzyme, and thus has no known interacting drugs or drug mechanisms[2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Golgin, RAB6-interacting (GORAB).